Cargando…

Five-year follow-up of 23 asymmetrical Parkinson's disease patients treated with unilateral subthalamic nucleus stimulation★

In this study, 23 asymmetrical Parkinson's disease patients were treated with unilateral deep brain stimulation of the subthalamic nucleus and followed up for 5 years. At 5 years after stimulation treatment, Unified Parkinson's Disease Rating Scale II, III and axial symptom scores in the o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Jinchuan, Hu, Xiaowu, Zhou, Xiaoping, Jiang, Xiufeng, Cao, Yiqun, Wang, Laixing, Jin, Aiguo, Liu, Jianmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308795/
https://www.ncbi.nlm.nih.gov/pubmed/25657677
http://dx.doi.org/10.3969/j.issn.1673-5374.2012.18.010
_version_ 1782354586762215424
author Liang, Jinchuan
Hu, Xiaowu
Zhou, Xiaoping
Jiang, Xiufeng
Cao, Yiqun
Wang, Laixing
Jin, Aiguo
Liu, Jianmin
author_facet Liang, Jinchuan
Hu, Xiaowu
Zhou, Xiaoping
Jiang, Xiufeng
Cao, Yiqun
Wang, Laixing
Jin, Aiguo
Liu, Jianmin
author_sort Liang, Jinchuan
collection PubMed
description In this study, 23 asymmetrical Parkinson's disease patients were treated with unilateral deep brain stimulation of the subthalamic nucleus and followed up for 5 years. At 5 years after stimulation treatment, Unified Parkinson's Disease Rating Scale II, III and axial symptom scores in the off-drug condition were significantly increased compared those at baseline. However, total Unified Parkinson's Disease Rating Scale II, III and axial symptom scores were significantly lower with stimulation-on compared with the synchronous stimulation-off state in off-drug condition, and the motor symptoms of contralateral side limbs were effectively controlled. Only low Hoehn-Yahr stage was correlated with good long-term postoperative improvement in motor symptoms. The mean levodopa-equivalent daily dose after stimulation treatment was significantly lower than that before treatment, but dyskinesias became worse. Our experimental findings indicate that unilateral deep brain stimulation of the subthalamic nucleus is an effective treatment for improving motor symptoms in well selected asymmetrical Parkinson's disease patients presenting no severe axial symptoms and dyskinesias.
format Online
Article
Text
id pubmed-4308795
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-43087952015-02-05 Five-year follow-up of 23 asymmetrical Parkinson's disease patients treated with unilateral subthalamic nucleus stimulation★ Liang, Jinchuan Hu, Xiaowu Zhou, Xiaoping Jiang, Xiufeng Cao, Yiqun Wang, Laixing Jin, Aiguo Liu, Jianmin Neural Regen Res Clinical Practice In this study, 23 asymmetrical Parkinson's disease patients were treated with unilateral deep brain stimulation of the subthalamic nucleus and followed up for 5 years. At 5 years after stimulation treatment, Unified Parkinson's Disease Rating Scale II, III and axial symptom scores in the off-drug condition were significantly increased compared those at baseline. However, total Unified Parkinson's Disease Rating Scale II, III and axial symptom scores were significantly lower with stimulation-on compared with the synchronous stimulation-off state in off-drug condition, and the motor symptoms of contralateral side limbs were effectively controlled. Only low Hoehn-Yahr stage was correlated with good long-term postoperative improvement in motor symptoms. The mean levodopa-equivalent daily dose after stimulation treatment was significantly lower than that before treatment, but dyskinesias became worse. Our experimental findings indicate that unilateral deep brain stimulation of the subthalamic nucleus is an effective treatment for improving motor symptoms in well selected asymmetrical Parkinson's disease patients presenting no severe axial symptoms and dyskinesias. Medknow Publications & Media Pvt Ltd 2012-06-25 /pmc/articles/PMC4308795/ /pubmed/25657677 http://dx.doi.org/10.3969/j.issn.1673-5374.2012.18.010 Text en Copyright: © Neural Regeneration Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Practice
Liang, Jinchuan
Hu, Xiaowu
Zhou, Xiaoping
Jiang, Xiufeng
Cao, Yiqun
Wang, Laixing
Jin, Aiguo
Liu, Jianmin
Five-year follow-up of 23 asymmetrical Parkinson's disease patients treated with unilateral subthalamic nucleus stimulation★
title Five-year follow-up of 23 asymmetrical Parkinson's disease patients treated with unilateral subthalamic nucleus stimulation★
title_full Five-year follow-up of 23 asymmetrical Parkinson's disease patients treated with unilateral subthalamic nucleus stimulation★
title_fullStr Five-year follow-up of 23 asymmetrical Parkinson's disease patients treated with unilateral subthalamic nucleus stimulation★
title_full_unstemmed Five-year follow-up of 23 asymmetrical Parkinson's disease patients treated with unilateral subthalamic nucleus stimulation★
title_short Five-year follow-up of 23 asymmetrical Parkinson's disease patients treated with unilateral subthalamic nucleus stimulation★
title_sort five-year follow-up of 23 asymmetrical parkinson's disease patients treated with unilateral subthalamic nucleus stimulation★
topic Clinical Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308795/
https://www.ncbi.nlm.nih.gov/pubmed/25657677
http://dx.doi.org/10.3969/j.issn.1673-5374.2012.18.010
work_keys_str_mv AT liangjinchuan fiveyearfollowupof23asymmetricalparkinsonsdiseasepatientstreatedwithunilateralsubthalamicnucleusstimulation
AT huxiaowu fiveyearfollowupof23asymmetricalparkinsonsdiseasepatientstreatedwithunilateralsubthalamicnucleusstimulation
AT zhouxiaoping fiveyearfollowupof23asymmetricalparkinsonsdiseasepatientstreatedwithunilateralsubthalamicnucleusstimulation
AT jiangxiufeng fiveyearfollowupof23asymmetricalparkinsonsdiseasepatientstreatedwithunilateralsubthalamicnucleusstimulation
AT caoyiqun fiveyearfollowupof23asymmetricalparkinsonsdiseasepatientstreatedwithunilateralsubthalamicnucleusstimulation
AT wanglaixing fiveyearfollowupof23asymmetricalparkinsonsdiseasepatientstreatedwithunilateralsubthalamicnucleusstimulation
AT jinaiguo fiveyearfollowupof23asymmetricalparkinsonsdiseasepatientstreatedwithunilateralsubthalamicnucleusstimulation
AT liujianmin fiveyearfollowupof23asymmetricalparkinsonsdiseasepatientstreatedwithunilateralsubthalamicnucleusstimulation